MYCN and neuroblastoma: In TARGET, GSE16476 and GSE62564 neuroblastoma cohorts, ROC curves showed the high specificity and sensitivity of ZNF436 in distinguishing MYCN amplified from MYCN non-amplified neuroblastoma patients (Fig. 5b).